Phase II study of cisplatin and 5-fluorouracil (PF) and mitomycin C, vincristine, cisplatin and 5-fluorouracil (MVPF) in patients with metastatic large bowel cancer: an Eastern Cooperative Oncology Group study (EST 1285).

MLA

Pandya, Kishan J., et al. “Phase II Study of Cisplatin and 5-Fluorouracil (PF) and Mitomycin C, Vincristine, Cisplatin and 5-Fluorouracil (MVPF) in Patients with Metastatic Large Bowel Cancer: An Eastern Cooperative Oncology Group Study (EST 1285).” Oncology, vol. 66, no. 2, 2004, pp. 118–25. EBSCOhost, https://doi.org/10.1159/000077437.

APA

Pandya, K. J., Lefkopoulou, M., Petrelli, N. J., Vaughn, D. J., Smith, T. J., Harris, J. E., & Haller, D. G. (2004). Phase II study of cisplatin and 5-fluorouracil (PF) and mitomycin C, vincristine, cisplatin and 5-fluorouracil (MVPF) in patients with metastatic large bowel cancer: an Eastern Cooperative Oncology Group study (EST 1285). Oncology, 66(2), 118–125. https://doi.org/10.1159/000077437

Chicago

Pandya, Kishan J, Myrto Lefkopoulou, Nicholas J Petrelli, David J Vaughn, Thomas J Smith, Jules E Harris, and Daniel G Haller. 2004. “Phase II Study of Cisplatin and 5-Fluorouracil (PF) and Mitomycin C, Vincristine, Cisplatin and 5-Fluorouracil (MVPF) in Patients with Metastatic Large Bowel Cancer: An Eastern Cooperative Oncology Group Study (EST 1285).” Oncology 66 (2): 118–25. doi:10.1159/000077437.